We further validated our hypothesis that impaired p53 status leads to proliferation and induction of survival signals in lung cancer cells, by treating two other lung cancer cells harboring mutant p53(Hop-92 and NCI-H522) with nicotine and curcumin. This evidence concerns the gene TP53 and lung cancer.